In addition, Fin56 can also induce GPX4 autophagic degradation and combined Fin56 with mTOR inhibitor enhances bladder cancer cell ferroptosis [73], suggesting that the combination of autophagy and ferroptosis inducers could effectively enhance cancer therapy. The gene discussed is GPX4; the disease is cancer.